Ari Green, MD, is chief of the Division of Neuroimmunology and Glial Biology in the Department of Neurology at UCSF and medical director of the UCSF MS/Neuroinflammation Center. Dr. Green’s laboratory is dedicated to the biological validation of potential biomarkers intended to measure remyelination and repair (as well as progression) in MS as a means to accelerate clinical trials for reparative treatments. Dr. Green is dedicated to ensuring outstanding care to people from throughout California, the US, and around the world. His team strongly believes in minimizing barriers to access for new discoveries and care, and has worked to expand relationships with San Francisco General Hospital, UCSF-Fresno and the broader community to expand access and opportunity, especially for patients with inflammatory and infectious diseases of the central nervous system. Dr. Green is also personally committed to social and health equity as well as education, having spent 2 years teaching in rural North Carolina via Teach for America in the early 1990s. He remains committed to social and health equity through the services that he and his team provide for patients outside of the UCSF health umbrella.
Dr. Green completed medical school at Duke University School of Medicine in 2001 and internship in the Department of Medicine at UCSF in 2002. He completed residency training including chief residency in neurology and fellowships in neuroimmunology and neuro-ophthalmology at UCSF. He then had a visiting fellowship at Queen’s University Belfast in neuropathology. He was named the first AAN/NMSS Clinician Science Fellow in 2005 and received a Howard Hughes Clinician Scientist award from HHMI. He was named as the Debbie and Andy Rachleff Distinguished Professor of Neurology in 2009 and joined the Department of Ophthalmology at UCSF in 2011. He was a Harry Weaver Neuroscience Scholar and has served as associate editor for JAMA Neurology since 2017.
Learn more about Dr. Green here.